Perseus Proteomics Inc. [4882.T]
TOKYO, May 14 (Pulse News Wire) – Perseus Proteomics Inc. (4882.T) reported its non-consolidated results for the nine months ended March 31, 2026, which included several extraordinary items impacting its financial performance.
For the quarter, the company recorded various non-operating revenues totaling ¥53.3 million. Specifically, grants amounted to __NUM_0__, foreign exchange gains reached ¥13.8 million, and interest income was ¥5.0 million. Additionally, the firm recognized non-operating expenses related to issuance costs of warrants amounting to ¥6.0 million.
Furthermore, Perseus Proteomics noted a special loss due to impairment of fixed assets, resulting in a charge of 37,260 thousand yen, based on accounting standards for asset impairments. These adjustments reflect the comprehensive impact on the company's financial statements during the reporting period. The detailed figures mentioned above are reflected in the company’s interim consolidated earnings release published today.
Investors should review the complete report for further insights into the company’s financial position and outlook.
🟢 Confidence: High AI-translated content.